HOME >> BIOLOGY >> NEWS
Mayo Clinic develops blood vessel cells from adult progenitor cells

ROCHESTER, Minn. -- Mayo Clinic scientists have shown for the first time that an adult stem cell variant circulating in adult human blood can be driven to form smooth muscle cells, which are key building blocks in blood vessel formation and also participate in coronary artery blockages. The findings are published in this week's edition of Circulation, the journal of the American Heart Association, and will be presented simultaneously at the European Society of Cardiology conference in Berlin.

The researchers used platelet-derived growth factor BB (PDGF-BB) to convert previously undiscovered circulating smooth muscle progenitor cells (SPCs) into smooth muscle outgrowth cells (SOCs). SPCs produced presumably reside in the bone marrow and are stem cells that have started down the path of cell differentiation. Scientists had suspected the existence of circulating SPCs because animal studies had shown that many smooth muscle cells found in atherosclerotic plaques or in restenosis after angioplasty had been partially derived from bone marrow.

The Mayo Clinic study is the first to prove the existence of SPCs in humans. In the presence of PGDF-BB, the cells rapidly proliferated into smooth muscle cells. These cells also had adhesive properties potentially steering the cells to areas of vessel blockages. According to first author, David Simper, M.D., the study may be a significant step in the potential development of new vessels (angiogenesis) to provide blood circulation to diseased hearts. "Previous studies have shown that endothelial cells, which line blood vessels can be grown from progenitors in blood," says Dr. Simper. "Smooth muscle cells are the essential building blocks of arteries, and until now we have not had a way to create them".

These new findings may help cardiologists address in a new way some of the key problems in interventional cardiology. "About 30 percent of patients with heart disease who have stents implanted during a
'"/>

Contact: Lee Aase
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
3-Sep-2002


Page: 1 2

Related biology news :

1. Creation of the UK Clinical Research Collaboration will boost clinical trials in UK
2. Hope Clinic of Emory Vaccine Center receives CDC contract
3. Clinical judgement still counts strongly alongside genetic testing
4. Jay Levy honored with 2004 Abbott Laboratories Award in Clinical and Diagnostic Immunology
5. Melvin Weinstein wins 2004 BD Award for Research in Clinical Microbiology
6. St. Jude/Mayo Clinic study finds direct link between CBP gene and lymphoma
7. DFG to establish seven new Clinical Research Units
8. Clinical trial patients dont care about study sponsors or physician conflicts of interest
9. NIH establishes Rare Diseases Clinical Research Network
10. Grant strengthens research arm of Penn State Hershey Medical Centers ALS Clinic
11. Clinical study reports findings of combination therapy with DOXIL

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Mayo Clinic develops blood vessel cells from adult progenitor cells

(Date:8/4/2015)... , Aug. 04, 2015 ... ) has announced the addition of the ... Software, and Service), Sub-Segment (Computer Forensics, Network ... Tool Types, Service, Vertical and Region - ... their offering. By Component (Hardware, ...
(Date:7/31/2015)... SHENZHEN, China , 31 de julio de 2015 ... sobre Genómica (ICG-10,  www.icg-10.org ) del 22 al 25 ... . La conferencia celebra su décimo ... se ha convertido en una de las reuniones anuales ... ,ómicas, y es una de las conferencias científicas más ...
(Date:7/31/2015)... 31. Juli 2015 Die 10. internationale Konferenz zu ... veranstaltet und findet vom 22. bis 25. Oktober ... statt. Die Konferenz feiert in ... 2006 ist die ICG weltweit zu einem der ... ist eines der dynamischsten, enthusiastischsten und angenehmsten wissenschaftlichen ...
Breaking Biology News(10 mins):Digital Forensics Market - The Market Represents a Compound Annual Growth Rate (CAGR) of 11.3% From 2015 to 2020 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 3Die 10. internationale Konferenz zu Genomik (ICG-10) beginnt im Oktober 2Die 10. internationale Konferenz zu Genomik (ICG-10) beginnt im Oktober 3
(Date:8/27/2015)... ... ... Inc. Magazine released its annual list of the 5,000 fastest-growing privately held companies ... three years through 2014. Being named to the Inc. 5000 list designates a company ... , “We are thrilled to make the Inc. 5000 list for 2015,” stated Tad ...
(Date:8/26/2015)... /PRNewswire/ - iCo Therapeutics ("iCo" or "the Company") (TSX-V: ... the quarter ended June 30, 2015. Amounts, unless ... presented under International Financial Reporting Standards ("IFRS"). ... our Oral Amp B program, rapidly advancing towards ... Andrew Rae , President & CEO of iCo ...
(Date:8/26/2015)... , Aug. 26, 2015 Intrexon Corporation (NYSE: ... today the closing of its previously announced public offering ... the underwriters of their option to purchase an additional ... price of $41.00 per share.  The exercise of the ... common stock sold by Intrexon to 5,609,756 shares and ...
(Date:8/26/2015)... ... 26, 2015 , ... PRC Clinical, a Clinical Trial Management Expert ... sponsors in southern California. The Clinical Trial Management Expert CRO seeks to introduce more ... , Stem Cell Meeting on the Mesa on ...
Breaking Biology Technology:iLab Solutions Named to 2015 Inc. 5000 List 2iLab Solutions Named to 2015 Inc. 5000 List 3iCo Therapeutics Announces Second Quarter 2015 Financial Results 2iCo Therapeutics Announces Second Quarter 2015 Financial Results 3Intrexon Announces Closing of $230 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares 2Intrexon Announces Closing of $230 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares 3Intrexon Announces Closing of $230 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares 4PRC Clinical To Attend Major Industry Conferences And Meet Sponsor Companies In The San Diego Biotech Hub 2PRC Clinical To Attend Major Industry Conferences And Meet Sponsor Companies In The San Diego Biotech Hub 3
Cached News: